Indefinite Delivery Contract SPE2DB20D1050

The Defense Logistics Agency awarded a single-award indefinite-delivery/indefinite-quantity contract to Amerisourcebergen Drug Corporation to supply pharmaceutical products in support of DLA's medical supply requirements. Task orders issued against the contract vehicle provide for delivery of various prescription and over-the-counter medications to customers of the Defense Logistics Agency from Amerisourcebergen's facility located in Conshohocken, Pennsylvania. Performance periods for the task orders extend from September 2023 through December 2025, with a potential value of $999,999,999. Amerisourcebergen Drug Corporation serves as the prime contractor to supply pharmaceuticals and medical supplies in fulfillment of the Defense Logistics Agency's mission to provide logistics support for the Department of Defense and other government agencies through efficient procurement and distribution programs worldwide.

The provided task order samples demonstrate orders awarded on a firm-fixed price basis for delivery of an array of prescription drugs and medical supplies to customers in the Conshohocken area. Products procured include medications for conditions such as seizures, infections, diabetes, allergies and cardiovascular issues. Vaccines, contrast agents and other medical commodities are also within scope. No set-aside designations or subcontracting arrangements are specified in the majority of task orders summarized. Place of performance and period of performance vary by individual order. Collectively the orders reflect the Defense Logistics Agency's process of leveraging pre-competed contracts to cost-effectively meet the pharmaceutical and medical supply needs of its customers.